DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 02 · Volume 23 · April 1997 DOI: 10.1055/s-002-7327

97
Mammen, Eberhard F.: Preface
99
Malsch, Reinhard; Guerrini, Marco; Berti, Carlo; Naggi, Annamaria; Torri, Giangiacomo; Casu, Benito; Harenberg, Job: Synthesis and Biological Effects of N-Alkylamine-Labeled Low-Molecular-Mass Dermatan Sulfate
109
Piazolo, Lukas; Harenberg, Job; Malsch, Reinhard; Hüttner, Franz G.; Heene, Dieter L.: Comparison of the Pharmacodynamic and Pharmacokinetic Profiles of Two Low-Molecular-Mass Heparins in Rats
119
Jeske, Walter; Fareed, Jawed; Eschenfelder, Volker; Iqbal, Omer; Hoppensteadt, Debra; Ahsan, Ahmad: Biochemical and Pharmacologic Characteristics of Reviparin, a Low-Molecular-Mass Heparin
129
Cella, Giuseppe; Vettor, Roberto; Sbarai, Alessandra; Rossi, Edoardo; Rampin, Ernesto; Macor, Cinzia; Mussap, Michele; Plebani, Mario; Luzzatto, Guido; Girolami, Antonio: Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (TFPI) Antigen in Severe Nondiabetic Obese Patients: Effect of Hyperinsulinemia
135
Pepe, Guglielmina; Giusti, Betti; Attanasio, Monica; Gori, Anna Maria; Comeglio, Paolo; Martini, Francesca; Gensini, Gianfranco; Abbate, Rosanna; Neri Serneri, Gian Gastone: Tissue Factor and Plasminogen Activator Inhibitor Type 2 Expression in Human Stimulated Monocytes is Inhibited by Heparin
143
Agnelli, Giancarlo; Sonaglia, Francesco: Recombinant Hirudin in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip Surgery
149
Bergqvist, David: Prolonged Prophylaxis in Postoperative Medicine
155
Turpie, Alexander G. G.: Prophylaxis of Venous Thromboembolism in Stroke Patients
159
Engelberg, Hyman: Evidence That Endogenous Heparin Activity Deficiency may be an Important Factor in Atherogenesis
167
Harenberg, Job; Huhle, Günter; Piazolo, Lukas; Giese, Christina; Heene, Dieter L.: Long-Term Anticoagulation of Outpatients with Adverse Events to Oral Anticoagulants Using Low-Molecular-Weight Heparin
173
Valentine, Karen A.; Hull, Russell D.; Pineo, Graham F.: Low-Molecular-Weight Heparin Therapy and Mortality
179
Breddin, Hans Klaus: Treatment of Deep Vein Thrombosis: Is Thrombosis Regression a Desirable Endpoint?
185
Prandoni, Paolo; Lensing, Anthonie W. A.; Prins, Martin R.: The Natural History of Deep-Vein Thrombosis
189
Harenberg, Job; Huhle, Günter; Piazolo, Lukas; Wang, Lianchun U.; Heene, Dieter L.: Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Type II
197
Lewis, Bruce E.; Walenga, Jeanine M.; Wallis, Diane E.: Anticoagulation with Novastan® (Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
203
Baumann, Hanno; Mueller, Udo; Keller, Ruprecht: Which Glycosaminoglycans Are Suitable for Antithrombogenic or Athrombogenic Coatings of Biomaterials? Part I: Basic Concepts of Immobilized GAGs on Partially Cationized Cellulose Membrane
215
Baumann, Hanno; Keller, Ruprecht: Which Glycosaminoglycans Are Suitable for Antithrombogenic or Athrombogenic Coatings of Biomaterials? Part II: Covalently Immobilized Endothelial Cell Surface Heparan Sulfate (ESHS) and Heparin (HE) on Synthetic Polymers and Results of Animal Experiments
225
Beijering, Rolinda J. R.; Cate, Hugo Ten; Nurmohamed, Michael T.; Ten Cate, Jan Wouter: Anticoagulants and Extracorporeal Circuits